FYARRO Trademark

Trademark Overview

On Friday, August 30, 2019, a trademark application was filed for FYARRO with the United States Patent and Trademark Office. The USPTO has given the FYARRO trademark a serial number of 88984193. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by AADi Bioscience, Inc.. The FYARRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
fyarro

General Information

Serial Number88984193
Word MarkFYARRO
Filing DateFriday, August 30, 2019
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6815686
Registration DateTuesday, August 9, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2019
Primary Code005
First Use Anywhere DateMonday, February 21, 2022
First Use In Commerce DateMonday, February 21, 2022

Trademark Owner History

Party NameAADi Bioscience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameAADi Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPacific Palisades, CA 90272
Party NameAADi Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPacific Palisades, CA 90272

Trademark Events

Event DateEvent Description
Tuesday, September 3, 2019NEW APPLICATION ENTERED
Thursday, September 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 4, 2019ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NON-FINAL ACTION WRITTEN
Wednesday, December 11, 2019NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 16, 2020ASSIGNED TO LIE
Wednesday, June 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 23, 2021SOU EXTENSION 1 FILED
Tuesday, February 23, 2021SOU EXTENSION 1 GRANTED
Thursday, February 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, September 20, 2021SOU EXTENSION 2 FILED
Monday, September 20, 2021SOU EXTENSION 2 GRANTED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022TEAS STATEMENT OF USE RECEIVED
Monday, March 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 21, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 5, 2022ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Monday, April 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2022DIVISIONAL REQUEST RECEIVED
Friday, May 6, 2022DIVISIONAL PROCESSING COMPLETE
Tuesday, March 22, 2022USE AMENDMENT FILED
Friday, May 6, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 1, 2022ASSIGNED TO EXAMINER
Tuesday, July 5, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 6, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, October 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

fyarro preparations pharmaceutical treatment albumin sirolimus physiological diseases nanoparticles oncology formulation